Loading color scheme
Monon Bioventures, LLC (MBV) is a privately held company helping scientists and physicians translate their pioneering innovations into life changing medical products. MBV is led by experienced business leaders with scientific backgrounds who understand how to develop medical products and build life science companies.
Diabetes is a disease of high blood sugar. Diabetic patients also can experience extremely low blood sugar, or hypoglycemia, after fasting, exercising or too large a dose of insulin. If untreated, severe hypoglycemia can lead to coma or even death.
Read moreScioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced it has closed on $1.8M in Series A financing to support the launch of its new microbiome platform technology.
Read moreToday Virtici, Celdara Medical and MBV announced their formation of the first collaborative nationwide network for the development of early stage biotechnologies. The goals are simple: to improve human health by identifying the highest potential innovations in medicine and developing them into the clinic.
Read more